| Literature DB >> 27110443 |
Andrea Soddu1, Francisco Gómez2, Lizette Heine3, Carol Di Perri3, Mohamed Ali Bahri3, Henning U Voss4, Marie-Aurélie Bruno3, Audrey Vanhaudenhuyse5, Christophe Phillips3, Athena Demertzi6, Camille Chatelle3, Jessica Schrouff3, Aurore Thibaut3, Vanessa Charland-Verville3, Quentin Noirhomme7, Eric Salmon3, Jean-Flory Luaba Tshibanda8, Nicholas D Schiff4, Steven Laureys9.
Abstract
INTRODUCTION: The mildly invasive 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a well-established imaging technique to measure 'resting state' cerebral metabolism. This technique made it possible to assess changes in metabolic activity in clinical applications, such as the study of severe brain injury and disorders of consciousness.Entities:
Keywords: Disorders of consciousness; FDG‐PET; ICA; fMRI; metabolism; resting state
Mesh:
Substances:
Year: 2015 PMID: 27110443 PMCID: PMC4834945 DOI: 10.1002/brb3.424
Source DB: PubMed Journal: Brain Behav Impact factor: 2.708
Clinical, electrophysiological and structural imaging data of the VS/UWS patients
| Clinical features | VS1 | VS2 | VS3 | VS4 | VS5 | VS6 | VS7 | VS8 | VS9 | VS10 | VS11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gender (age, years) | Male (49) | Female (38) | Female (53) | Female (63) | Male (28) | Female (69) | Male (57) | Male (36) | Male (48) | Female (32) | Female (73) |
| Cause | Cerebro vascular accident | Anoxia | Hypoglycemia | Cerebro vascular accident | Anoxia | Anoxia | Traumatic | Anoxia | Anoxia | Anoxia | Oclusion basilar artery |
| Time of fMRI (days after admission) | 2884 | 1.730 | 24 | 32 | 93 | 61 | 24 | 2036 | 140 | 486 | 60 |
| Clinical evaluation at time of fMRI | VS | VS | VS | VS | VS | VS | VS | VS | VS | VS | VS |
| Coma Recovery scale‐Revised total score | 7 | 5 | 5 | 6 | 5 | 4 | 1 | 7 | 4 | 5 | 5 |
| Auditory function | Auditory startle | Auditory startle | Auditory startle | Auditory startle | Auditory startle | None | None | Auditory startle | Auditory startle | Auditory startle | Auditory startle |
| Visual function | Blinking to threat | None | None | Blinking to threat | None | None | None | None | None | None | None |
| Motor function | Abnormal posturing | Abnormal posturing | Flexion withdrawal | Abnormal posturing | Abnormal posturing | Flexion withdrawal | None | Abnormal posturing | None | Flexion withdrawal | Flexion withdrawal |
| Oromotor/Verbal function | Vocalization/Oral movement | Oral reflexive movement | Oral reflexive movement | Oral reflexive movement | Oral reflexive movement | Oral reflexive movement | None | Vocalization/Oral movement | Oral reflexive movement | Oral reflexive movement | Oral reflexive movement |
| Communication | None | None | None | None | None | None | None | None | None | None | None |
| Arousal | Eyes open without stimulation | Eyes open without stimulation | Eyes open with stimulation | Eyes open with stimulation | Eyes open without stimulation | Eyes open with stimulation | Eyes open with stimulation | Eyes open without stimulation | Eyes open without stimulation | Eyes open with stimulation | Eyes open with stimulation |
| EEG | |||||||||||
| Background activity | Delta‐theta irregular | Background symmetric rhythm of 8–9 Hz | Low voltage background symmetric rhythm of 3–4 Hz | Irregular symmetric rhythm of 4–5 Hz | Isoelectric activity with eye‐induced artefacts | Diffuse 3–4 hz activity, mainly in frontal regions | Irregular symmetric rhythm of 5–6 Hz, Moderate encephalopathy with brainstem suffering | Background symmetric rhythm of 7 Hz with intermittent slow activity | Predominance of slow bilateral delta activity of low amplitude with burst of slow waves of higher amplitude | Predominance of slow bilateral delta | Predominance of slow bilateral delta activity of low amplitude with burst of slow waves of higher amplitude |
| MRI | |||||||||||
| Diffuse cortical atrophy. Quadriventricular hydrocephaly | Diffuse cortico‐subcortical atrophy. Diffuse leucoencephalopathy | Brainstem, thalamic and diffuse cortical lesions. Precuneal and subcortical encephalopathy. Diffuse corpus callosum athrophy | Bilateral cerebellar ischemic lesions pronounced on the left side and extended to the vermis and left cerebellar peduncle | Diffuse leukoencephalopaty with bihemispheric cortical ischemic sequels | Diffuse cortico‐sub‐cortical and thalamic lesions. Bilateral hypocampal athrophy | Bilateral cerebellar ischemic lesions pronounced on the left side and extended to the vermis and left cerebellar peduncle | Diffuse athrophy. Quadriventricular hydrocephaly | Periventricular leukoencephalopathy. Cortico‐spinal tract degeneration | Diffuse cortical‐subcortical atrophy. Cortical‐thalamus and basal ganglia ischemic sequels. Periventricular leukoencephalopahty | Ischemic lesions with hemorrhagic infarction in cerbellar hemispheres, right thalamus and right occipital lobe | |
VS, vegetative state; UWS, unresponsive wakefulness syndrome, fMRI, functional magnetic resonance imaging, EEG, electroencephalography .
Clinical features of LIS patients
| Clinical features | LIS1 | LIS2 | LIS3 | LIS4 |
|---|---|---|---|---|
| Diagnosis | Classical LIS | Functional LIS | Classical LIS | Classical LIS |
| Gender (age, years) | Male (20) | Female (36) | Female (28) | Female (54) |
| Etiology | Traumatic | Cerebro vascular accident | Cerebro vascular accident | Traumatic |
| Time of fMRI (years/months) | 4j 5 m | 6j 2 m | 5j 9 m | 5j 10 m |
LIS, locked‐in syndrome; fMRI, functional magnetic resonance imaging.
Figure 1Pictorial description of the methodology used to construct the fMRI total neuronal scalar map starting from automatically selected neuronal independent components. Neuronal independent components were selected based on their fingerprint, which describes for each component, spatial properties of the distribution of the Z scores as extracted from the spatial map and temporal properties as extracted from the corresponding time course. The green line on the fingerprint represent the mean values obtained from an independent group of normal volunteers, the red line represents the values observed in the assessed subject.
Figure 2Scatter plots for all the 16 healthy controls showing the correlation between the FDG‐PET after partial volume correction versus the fMRI‐total neuronal activity for voxels belonging to gray matter. Solid line indicates the best linear fit to the data and on the upper left corner of each scatter plot the linear correlation value is reported.
Figure 3(A) fMRI total neuronal (B) SUV obtained from FDG‐PET without partial volume correction (C) SUV obtained from FDG‐PET after partial volume correction for our group of 16 healthy controls in four coronal slices.
Figure 4Voxel‐based between‐group analysis for (A) FDG‐PET describing regions (in orange) with higher metabolic activity in healthy controls (CTR) with respect to vegetative state/unresponsive wakefulness syndrome patients (VS/UWS), and regions preserved in vegetative state/unresponsive wakefulness syndrome patients (P < 0.05 FDR corrected). (B) fMRI total neuronal activity as for A. (C) conjunction of FDG‐PET and fMRI total neuronal as for a. In green regions with a higher decrease in FDG‐PET with respect to fMRI total neuronal and in red with a higher decrease in fMRI total neuronal with respect to FDG‐PET (for the contrast healthy controls more than vegetative state/unresponsive wakefulness syndrome patients). FDG‐PET was partial volume corrected.
Regions with highest Z value appearing in the contrasts healthy controls (CTR) more than vegetative state/unresponsive wakefulness syndrome patients (VS/UWS) and preserved in vegetative state/unresponsive wakefulness syndrome patients for the three cases of FDG‐PET, fMRI total neuronal and conjunction analyses of FDG‐PET and fMRI. Regions with highest Z values corresponding to a higher decrease in FDG‐PET with respect to fMRI total neuronal and with a higher decrease in fMRI total neuronal with respect to FDG‐PET (for the contrast healthy controls more than vegetative state/unresponsive wakefulness syndrome patients). Regions are shown in talaraich space
| Brain region |
|
|
|
|---|---|---|---|
| FDG‐PET (CTR > VS/UWS) | |||
| Superior gyrus | −17, 11, 58 | 3.9 | <0.001 |
| Medial frontal cortex | 1, 43, 28 | 3.7 | <0.001 |
| Precuneus | 0, −64, 36 | 7.0 | <0.001 |
| FDG‐PET (Preserved) | |||
| Brainstem | 1, −29, −18 | 4.7 | <0.001 |
| fMRI total neuronal (CTR > VS/UWS) | |||
| Intraparietal cortex | −57, 52, 25 | 3.7 | <0.001 |
| Temporal cortex Left/Right | 62, −23, −17 | 3.3 | <0.001 |
| Medial orbitofrontal cortex | 0, 45, −10 | 3.8 | <0.001 |
| fMRI total neuronal (Preserved) | |||
| Hipothalamus | −1.8, −3.5, −7.5 | 3.9 | <0.001 |
| PET‐fMRI conjunction (CTR > VS/UWS) | |||
| Precuneus | −0, −56, 13 | 2.9 | <0.001 |
| Intraparietal cortex | 46, −40, 46 | 3.7 | <0.001 |
| Inferior frontal gyrus Left/Right | −54, 13, 15 | 2.0 | <0.001 |
| Medial frontal gyrus Left/Right | −48, 12, 26 | 2.3 | <0.001 |
| PET > fMRI (CTR > VS/UWS) | |||
| Precuneus | −0.9, −65, 43 | 3.2 | <0.001 |
| Insula | −43, 19, −3 | 3.6 | <0.001 |
| Caudate | 13, 6, 12 | 5.0 | <0.001 |
| Thalamus | −8, −26, 6 | 4.0 | <0.001 |
| PET < fMRI (CTR > VS/UWS) | |||
| Medial prefrotal cortex | 6, 40, −7 | 3.8 | <0.001 |
| Brainstem | 4, −4, 21 | 3.6 | <0.001 |
| Amigdala | 30, −7, 21 | 4.0 | <0.001 |
FDG‐PET, 18F‐fluorodeoxyglucose positron emission tomography; fMRI, functional magnetic resonance imaging.
Figure 5Voxel‐based analysis for the conjunction of FDG‐PET and fMRI total neuronal describing regions with higher metabolic activity in healthy controls compared to vegetative state/unresponsive wakefulness syndrome patients (in orange). The mean Z‐scores and 90% confidence interval for the connectivity in the precuneus, the medial frontal gyrus, the left lateral posterior parietal, and the left middle frontal gyrus are visualized for healthy controls, locked in syndrome patients (LIS) and vegetative state/unresponsive wakefulness syndrome patients (VS/UWS) for both fMRI total neuronal and FDG‐PET activity.
Figure 6Average fMRI total neuronal activity over gray matter voxels versus total number of neuronal components combining all subjects, healthy controls (CTR), locked‐in (LIS) syndrome patients and vegetative state/unresponsive wakeful syndrome (VS/UWS) patients. Solid line indicates the best linear fit to the data and on the upper right corner the linear correlation value with its corresponding P‐value are reported.